Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front - PubMed (original) (raw)
Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front
T Brabletz et al. Pathol Res Pract. 1998.
Abstract
Sixty to eighty percent of all colorectal cancers are characterized by mutations in the APC tumor suppressor gene. Recently, it was shown that these mutations lead to a nuclear overexpression of beta-Catenin by disruption of the wingless/WNT signal pathway. Since nuclear beta-Catenin functions as a transcriptional activator of hitherto unknown tumor genes, this form of beta-Catenin is now considered a major oncoprotein in colorectal cancer. Using immunohistochemistry, we investigated the distribution of overexpressed beta-Catenin within individual colorectal carcinomas. In the majority of the tumors, we found no homogeneous staining, but a strong nuclear expression of beta-Catenin predominantly localized at the invasion front with strongest nuclear staining of isolated, scattered tumor cells. In contrast, cells in the tumor center often showed no nuclear staining, but retained a membranous expression of beta-Catenin, comparable to normal colon epithelium. It is, therefore, likely that in addition to the overexpression of beta-Catenin caused by defects in the APC locus, regulatory events in the tumor itself lead to a different distribution of this oncoprotein. Possibly, surrounding tissue at the invasion front can give signals to the tumor cells, leading to a nuclear translocation of beta-Catenin, where it may play a direct role in tumor invasion processes.
Similar articles
- Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers.
Aust DE, Terdiman JP, Willenbucher RF, Chew K, Ferrell L, Florendo C, Molinaro-Clark A, Baretton GB, Löhrs U, Waldman FM. Aust DE, et al. Mod Pathol. 2001 Jan;14(1):29-39. doi: 10.1038/modpathol.3880253. Mod Pathol. 2001. PMID: 11211307 - MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis.
Baldus SE, Mönig SP, Huxel S, Landsberg S, Hanisch FG, Engelmann K, Schneider PM, Thiele J, Hölscher AH, Dienes HP. Baldus SE, et al. Clin Cancer Res. 2004 Apr 15;10(8):2790-6. doi: 10.1158/1078-0432.ccr-03-0163. Clin Cancer Res. 2004. PMID: 15102686 - Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin.
Brabletz T, Hlubek F, Spaderna S, Schmalhofer O, Hiendlmeyer E, Jung A, Kirchner T. Brabletz T, et al. Cells Tissues Organs. 2005;179(1-2):56-65. doi: 10.1159/000084509. Cells Tissues Organs. 2005. PMID: 15942193 Review. - Beta-catenin activates a coordinated expression of the proinvasive factors laminin-5 gamma2 chain and MT1-MMP in colorectal carcinomas.
Hlubek F, Spaderna S, Jung A, Kirchner T, Brabletz T. Hlubek F, et al. Int J Cancer. 2004 Jan 10;108(2):321-6. doi: 10.1002/ijc.11522. Int J Cancer. 2004. PMID: 14639622 - [Dysfunction of E-cadherin-catenin system in invasion and metastasis of colorectal cancer].
Maruyama K, Ochiai A, Nakamura S, Baba S, Hirohashi S. Maruyama K, et al. Nihon Geka Gakkai Zasshi. 1998 Jul;99(7):402-8. Nihon Geka Gakkai Zasshi. 1998. PMID: 9742518 Review. Japanese.
Cited by
- Restoring mechanophenotype reverts malignant properties of ECM-enriched vocal fold cancer.
Kaivola J, Punovuori K, Chastney MR, Miroshnikova YA, Abdo H, Bertillot F, Krautgasser F, Franco JD, Conway JRW, Follain G, Hagström J, Mäkitie A, Irjala H, Ventelä S, Hamidi H, Scita G, Cerbino R, Wickström SA, Ivaska J. Kaivola J, et al. bioRxiv [Preprint]. 2024 Aug 23:2024.08.22.609159. doi: 10.1101/2024.08.22.609159. bioRxiv. 2024. PMID: 39372730 Free PMC article. Preprint. - AIDDISON: Empowering Drug Discovery with AI/ML and CADD Tools in a Secure, Web-Based SaaS Platform.
Rusinko A, Rezaei M, Friedrich L, Buchstaller HP, Kuhn D, Ghogare A. Rusinko A, et al. J Chem Inf Model. 2024 Jan 8;64(1):3-8. doi: 10.1021/acs.jcim.3c01016. Epub 2023 Dec 22. J Chem Inf Model. 2024. PMID: 38134123 Free PMC article. - Possible correlation of apical localization of MUC1 glycoprotein with luminal A-like status of breast cancer.
Semba R, Horimoto Y, Sakata-Matsuzawa M, Ishizuka Y, Denda-Nagai K, Fujihira H, Noji M, Onagi H, Ichida M, Miura H, Watanabe J, Saito M, Saito T, Arakawa A, Irimura T. Semba R, et al. Sci Rep. 2023 Mar 31;13(1):5281. doi: 10.1038/s41598-023-32579-4. Sci Rep. 2023. PMID: 37002293 Free PMC article. - To β or Not to β: Lack of Correlation Between APC Mutation and β-Catenin Nuclear Localization in Colorectal Cancer.
Bala P, Kavadipula P, Sarkar S, Bashyam MD. Bala P, et al. J Gastrointest Cancer. 2023 Dec;54(4):1181-1184. doi: 10.1007/s12029-022-00886-0. Epub 2022 Dec 31. J Gastrointest Cancer. 2023. PMID: 36586069 - Transcriptional and post-transcriptional control of epithelial-mesenchymal plasticity: why so many regulators?
Migault M, Sapkota S, Bracken CP. Migault M, et al. Cell Mol Life Sci. 2022 Mar 12;79(3):182. doi: 10.1007/s00018-022-04199-0. Cell Mol Life Sci. 2022. PMID: 35278142 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous